Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 29, 2026
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.
Journal: Neurology
Published: July 17, 2024
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 study.
Journal: Multiple sclerosis and related disorders
Published: July 09, 2024
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
Journal: Neurology. Clinical practice
Published: April 03, 2024
Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.
Journal: Multiple sclerosis and related disorders
Published: April 24, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.
Journal: Multiple sclerosis and related disorders
Published: April 06, 2023
Comparison of dimethyl fumarate and interferon outcomes in an MS cohort.
Journal: BMC neurology
Published: March 22, 2022
Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple Sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 17, 2021
Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 26, 2020
Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis.
Journal: Multiple sclerosis international
Published: June 22, 2020
A possible case of serum sickness after ocrelizumab infusion.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 20, 2020
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
Journal: Journal of neurology
Published: May 01, 2020
Last Updated: 09/26/2026